Responsiveness of myasthenia gravis lymphocytes to recombinant interleukin-2.
Cohen-Kaminsky
S
S
CNRS UA 04-1159, Centre Chirurgical Marie-Lannelongue, Le Plessis-Robinson, France.
Berrih-Aknin
S
S
Safar
D
D
D004305:Dose-Response Relationship, Drug; D006801:Humans; D066298:In Vitro Techniques; D007376:Interleukin-2 / Q000494:pharmacology*; D008213:Lymphocyte Activation / Q000187:drug effects; D008214:Lymphocytes / Q000276:immunology*; D009157:Myasthenia Gravis / Q000276:immunology*; D011994:Recombinant Proteins / Q000494:pharmacology; D013950:Thymus Gland / Q000166:cytology; D013997:Time Factors
D007376:Interleukin-2; D011994:Recombinant Proteins